The $15 Billion Question: What Healthcare Leaders Should Take Away from the Latest IDR Data
By the BillWell Revenue Strategy Team
The No Surprises Act changed how providers and payers resolve out-of-network reimbursement. Now, newly released federal data is changing the conversation again.
While the law successfully protected patients from unexpected medical bills, it also fundamentally changed how providers and payers resolve reimbursement disputes.
Now, new federal data is bringing renewed attention to the Independent Dispute Resolution (IDR) process.
According to a recent analysis of Centers for Medicare & Medicaid Services (CMS) data, healthcare providers recovered nearly $15 billion through the federal IDR process in 2025—more than three times the amount reported the previous year.
For healthcare executives, the significance isn’t simply the size of that number.
It is what the data suggests about the reimbursement opportunities that may exist within individual organizations.
Latest Federal IDR Snapshot
- Nearly $15 billion recovered by providers through federal IDR in 2025
- More than three times the amount reported the previous year
- 1.4 million disputes filed during the first five months of 2026
- Providers prevailed in approximately 88% of payment determinations during the first half of 2025
The $15 billion figure reflects provider recoveries reported for 2025, while the 1.4 million disputes represent filings during the first five months of 2026.
The IDR Process Has Become a Significant Part of Healthcare Reimbursement
When Congress passed the No Surprises Act, the goal was clear:
Protect patients from unexpected medical bills.
What many organizations didn’t anticipate was how quickly the IDR process would become a significant component of provider reimbursement.
Federal officials originally projected roughly 22,000 arbitration disputes annually.
Instead, more than 1.4 million disputes were filed during just the first five months of 2026, underscoring how extensively the process is now being used.
For many provider organizations, particularly those caring for out-of-network patients, the revenue cycle doesn’t necessarily end when a claim is paid—or denied. The question is whether the reimbursement ultimately received reflects the value of the care already delivered.
Certain Specialties Continue to See the Greatest Impact
The organizations most frequently involved in IDR aren’t random.
Many represent specialties where patients often have little or no ability to choose their provider, including:
- Anesthesiology
- Emergency Medicine
- Radiology
These specialties have consistently generated a significant share of federal IDR disputes and have frequently prevailed in arbitration.
This isn’t surprising.
These providers routinely deliver medically necessary care while reimbursement negotiations occur after services have already been rendered.
For organizations operating in these specialties, understanding the IDR process is increasingly part of understanding the broader reimbursement environment.
Providers Continue to Prevail in Arbitration
Another notable trend is the consistency of arbitration outcomes.
Recent CMS data indicates providers prevailed in approximately 88% of payment determinations during the first half of 2025.
That statistic has fueled ongoing debate among provider organizations, insurers, regulators, and policymakers.
That debate has intensified in recent weeks: insurer trade groups have publicly characterized rising IDR payouts as evidence of a system being “gamed,” and members of Congress have opened new oversight inquiries into how certified IDR entities decide claims.
Regardless of where those policy discussions ultimately lead, the results demonstrate something important:
IDR can materially change the outcome of a reimbursement dispute.
And the impact isn’t limited to the national numbers.
What the Opportunity Can Look Like at the Provider Level
National statistics tell one part of the story.
Provider-level results demonstrate what those opportunities can look like inside individual organizations.
Across four provider organization scorecards, BillWell’s internal reporting documented more than $62.8 million in total IDR awards.
Of that amount, more than $60.4 million represented increases above the providers’ initial payments.
The same scorecards documented:
- 3,416 full wins
- 1,672 partial wins
- Combined full- and partial-win rates ranging from 99.4% to 100% across the organizations represented
These results are based on internal scorecards and are not intended to represent the results every organization should expect.
But they illustrate an important point:
The difference between an initial payment and appropriate reimbursement can be substantial.
And that difference may already exist within claims an organization has considered finished.
The Bigger Question Isn’t $15 Billion
The more important question for most healthcare organizations is much simpler:
What opportunities may already exist within your own claims inventory?
Many organizations focus heavily on generating additional patient volume.
Far fewer routinely evaluate whether historical out-of-network claims contain reimbursement opportunities that were never fully pursued.
Recovering additional reimbursement doesn’t necessarily require:
- More operating rooms
- More providers
- More clinic hours
- More patients
Sometimes it begins with evaluating work that’s already been performed.
That distinction matters.
Because finding additional revenue through new volume requires the organization to create something new.
Finding overlooked reimbursement may simply require the organization to look differently at what it already has.
The Opportunity Extends Beyond Individual Claims
A disciplined reimbursement strategy isn’t simply about winning arbitration.
The information generated through the process can also provide insight into broader reimbursement performance.
It can help organizations:
- Improve cash flow
- Strengthen long-term reimbursement strategy
- Gain greater insight into payer behavior
- Support physician recruitment and retention
- Reinvest in technology and patient care
Viewed this way, IDR becomes more than a dispute resolution process.
It becomes part of a broader revenue optimization strategy.
The organizations that approach reimbursement this way aren’t simply asking, “Did we win this claim?”
They’re asking what their claims, payment outcomes, and payer patterns are telling them about the business as a whole.
What Healthcare Leaders Should Be Asking
Rather than focusing solely on whether an organization participates in IDR, healthcare leaders should consider a broader set of questions:
- Are we looking at the claims we already have—not just the revenue we are trying to generate?
- How are we determining which historical claims may warrant further reimbursement review?
- What does our claims data tell us about payer behavior and reimbursement outcomes?
- Are eligible opportunities being consistently identified and pursued?
- What would our reimbursement results look like if we systematically evaluated the opportunities already within our claims inventory?
These aren’t simply billing questions.
They’re strategic revenue questions.
And answering them requires looking beyond individual claims to understand the patterns within an organization’s reimbursement data.
Final Thoughts
The conversation surrounding the No Surprises Act will undoubtedly continue to evolve as policymakers, insurers, and providers debate the future of the IDR process.
But one principle remains unchanged:
Healthcare organizations deserve appropriate reimbursement for medically necessary care.
The latest federal data demonstrates the scale of the IDR opportunity.
Provider-level results demonstrate that the financial impact can be significant.
And for healthcare organizations, the next question may be much closer to home:
What opportunities are already sitting inside your existing claims inventory?
Organizations that proactively evaluate those opportunities may uncover one of the most meaningful financial resources already within their business.
What Opportunities May Already Exist Within Your Claims Inventory?
BillWell helps healthcare organizations identify overlooked reimbursement opportunities, evaluate historical claims, and navigate the complexities of the federal IDR process.
Could your existing claims represent a larger financial opportunity than you realize?
Sources
- Centers for Medicare & Medicaid Services (CMS) – Federal Independent Dispute Resolution (IDR) Reports — Federal IDR Public Use Files (PUFs), supplemental tables, bi-monthly reports, and payment determination data.
- The Wall Street Journal – “Medical Billing Arbitration Paid Out $15 Billion to Providers in Surprise Bill Disputes” — Analysis of newly released CMS data detailing nearly $15 billion in provider recoveries through the federal IDR process in 2025.
- Becker’s Payer Issues – “Providers Won 88% of No Surprises IDR Determinations in Early 2025” — Summary of CMS payment determination data showing provider success rates in federal IDR.
- American College of Radiology (ACR) – “Providers Win in Most Disputed Surprise Billing Cases” — Review of arbitration outcomes and the impact of the No Surprises Act on physician reimbursement.
BillWell internal reporting: Aggregate results from four provider organization KPI scorecards, reflecting reported IDR results as of September 8, 2026. Results are presented in aggregate without identifying individual organizations.
Disclaimer
This article is intended for informational purposes only and should not be construed as legal or reimbursement advice. Information is based on publicly available sources and BillWell internal reporting available at the time of publication. Organizations should consult qualified legal and reimbursement professionals regarding their specific circumstances.
